www.guidrynews.com/05Community/33905HoustonVA.htm -
[Cached Version]
Published on: 12/5/2005
Last Visited: 12/6/2005
The driving force behind the formation of the new Colorectal Cancer Center at the Michael E. DeBakey VA Medical Center is its director, Daniel Albo, M.D., Ph.D., chief of General Surgery and Surgical Oncology at the MEDVAMC and assistant professor of Surgery in the Department of Surgery at Baylor College of Medicine.
...
The driving force behind the formation of the new center is its director, Daniel Albo, M.D., Ph.D., chief of General Surgery and Surgical Oncology at the MEDVAMC and assistant professor of Surgery in the Department of Surgery at Baylor College of Medicine.Albo assembled a multi-disciplinary team comprised of surgeons, hematology specialists, surgical oncologists, nurses, physician assistants, surgical residents, social workers, and radiologists.Recruitment for an additional surgical oncologist has also begun.
Three other key components of the new center are a large database already established by Albo with information on patient with colorectal cancer diagnosed at the MEDVAMC in the last 10 years, a large tissue sample database, and tissue and blood sample repositories.These tools will allow MEDVAMC surgeons and physicians to follow recently diagnosed patients, track the progress of patients who have received treatment, and analyze patient data.
" Colon and rectal cancer can be very lethal.More than half of individuals with colorectal cancer have a chance of reoccurrence.Of those patients, 85 percent reoccur in the first two and half years.Recent studies have shown that intense follow up during this period leads to earlier detection, higher rates of therapeutic resection for recurrences, and an improvement in patient outcomes," said Albo.